Publications by authors named "Laurent Mathiot"

Claim this Profile
R
Real-world analysis of HER2-ultralow in HR+/HER2- metastatic breast cancer: prevalence and first-line chemotherapy outcomes.
Laurent Mathiot, Olivier Kerdraon, Florent Le Borgne, Véronique Verriele, Anne Patsouris

Ther Adv Med Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on ``Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung Cancer''.
Laurent Mathiot, Judith Raimbourg

Clin Lung Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study.
Jean-Sébastien Frenel, Laurent Mathiot, Claire Cropet, Edith Borcoman, Alice Hervieu

J Immunother Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring concentration and lipid signature of plasma extracellular vesicles from HR metastatic breast cancer patients under CDK4/6 inhibitors treatment.
Mathilde Richard, Rosalie Moreau, Mikaël Croyal, Laurent Mathiot, Jean-Sébastien Frénel

J Extracell Biol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review.
Laurent Mathiot, Capucine Baldini, Octave Letissier, Antoine Hollebecque, Rastislav Bahleda

Curr Oncol Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature.
Marine Aubert, Laurent Mathiot, Hélène Vegas, Lobna Ouldamer, Claude Linassier

Oncologist· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung Cancer.
Laurent Mathiot, Benoit Nigen, Thomas Goronflot, Sandrine Hiret, Ludovic Doucet

Clin Lung Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors.
Laurent Mathiot, David Combarel, Justin Cagnat, Julia Delahousse, Kaissa Ouali

J Immunother Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of first-line immunotherapy on survival and intracranial outcomes in a cohort of non-small cell lung cancer patients with brain metastases at diagnosis.
Benoit Nigen, Thomas Goronflot, Guillaume Herbreteau, Laurent Mathiot, Christine Sagan

Lung Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature.
Laurent Mathiot, Guillaume Herbreteau, Siméon Robin, Charlotte Fenat, Jaafar Bennouna

Curr Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis